First-in-human study of the safety, pharmacokinetics, and

Zhimeng Biopharma Announces Dosing of First Subject in First-in

Frontiers Progress of potential drugs targeted in lipid metabolism research

First-In-Human Clinical Trial Requirement -BioPharma Services

PDF) First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors

PDF] A first-in-human study to investigate the safety

The phases of preclinical and clinical trials

Frontiers Application of Pharmacokinetic-Pharmacodynamic

Learning from tragedy: safety and dosing in first-in-human trials

MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma

Shubham Pant MD Anderson Cancer Center

Database of pharmacokinetic time-series data and parameters for

Fatty Acid Metabolism: A New Perspective in Breast Cancer Precision Therapy

Planning Your (First) First-in Human Trial? Considerations for